Inscinstech Co., Ltd.
PrivateLast Round
Series C
Jan 18, 2025
Total Funding Raised
$36.4M
Company Overview
Inscinstech Co., Ltd. operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series C round in January 2025.
Inscinstech Co., Ltd. is a biotechnology company that provides comprehensive solutions for biopharmaceutical CMC processes, including laboratory analysis, upstream culture, and downstream purification equipment.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology, Workflow Automation
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inscinstech Co., Ltd. Comparables
Compare Inscinstech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Taidu Biotech (Suzhou) Co., Ltd. | 85% | |
| Opentrons | 78% | |
| Tecan Group Ltd. | 74% |
For institutional investors. Book with your work email.
Inscinstech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 18, 2025 | ||||
| Series B Extension | Jan 4, 2023 | ||||
| Series B | Nov 1, 2022 | ||||
| Series A Extension | Feb 1, 2022 | ||||
| Series A | Oct 1, 2021 | ||||
Early Funding | Apr 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inscinstech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Series C |
| Luxin Venture Capital Group Co., Ltd. | Series B |
| China Merchants Capital | Series C |
| Luxin Venture Capital Group | Series C |
| Addor Capital | Series B |
| Qiming Venture Partners | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 18, 2025
$27M round led by China Merchants Capital
- Jan 4, 2023
Led by Qiming Venture Partners.
For institutional investors. Book with your work email.
Inscinstech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inscinstech Co., Ltd.'s valuation, stock price, and market status.
Is Inscinstech Co., Ltd. a public or private company?
Inscinstech Co., Ltd. is a private company.
What is the current stock price of Inscinstech Co., Ltd.?
Inscinstech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Inscinstech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inscinstech Co., Ltd. worth (valuation)?
Valuation information for Inscinstech Co., Ltd. is not publicly available.
Can I buy Inscinstech Co., Ltd. stock?
Inscinstech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inscinstech Co., Ltd.'s last funding round?
Inscinstech Co., Ltd.'s most recent funding round was Series C on January 18, 2025.
Who are the main investors in Inscinstech Co., Ltd.?
Key investors in Inscinstech Co., Ltd. include Luxin Venture Capital Group Co., Ltd., China Merchants Capital, Qiming Venture Partners.
Will Inscinstech Co., Ltd. IPO soon?
No public IPO plans have been announced for Inscinstech Co., Ltd..
How can I track Inscinstech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Inscinstech Co., Ltd.'s shares on secondary markets.